Wang, Yinxiang
9Jacobio Pharmaceuticals Group Co., Ltd., Beijing, China.
2 papers on CoChatORCID 0009-0006-9039-9263
Most cited papers
- Verified
JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
Kang, D., Wang, Y., Lin, Y., Ma, W. W., Morgensztern, D., Leventakos, K., Bi, C., Ding, Y., Xiong, J., Yan, M., et al. (2025) · Clinical Cancer Research
Protein Tyrosine PhosphatasesMelanoma and MAPK Pathways
Cited by 17
- Verified
Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312
Wang, P., Sun, X., He, X., Kang, D., Liu, X., Liu, D., Li, A., Yang, G., Lin, Y., Li, S., et al. (2025) · Cancer Research Communications
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free